[go: up one dir, main page]

WO2007065032A3 - Composes et methodes permettant d'inhiber une entree virale - Google Patents

Composes et methodes permettant d'inhiber une entree virale Download PDF

Info

Publication number
WO2007065032A3
WO2007065032A3 PCT/US2006/046399 US2006046399W WO2007065032A3 WO 2007065032 A3 WO2007065032 A3 WO 2007065032A3 US 2006046399 W US2006046399 W US 2006046399W WO 2007065032 A3 WO2007065032 A3 WO 2007065032A3
Authority
WO
WIPO (PCT)
Prior art keywords
viral entry
compounds
methods
inhibiting viral
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/046399
Other languages
English (en)
Other versions
WO2007065032A2 (fr
Inventor
Jacquelyn Gervay-Hague
Christopher D Meadows
Thomas W North
Yen T Duong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of WO2007065032A2 publication Critical patent/WO2007065032A2/fr
Publication of WO2007065032A3 publication Critical patent/WO2007065032A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette invention concerne une série de composés contenant des disulfones géminaux qui conviennent pour le traitement du VIH. Un inhibiteur de stade précoce agit comme co-récepteur de petites molécules/inhibiteur indépendant d'entrée virale et peut s'utiliser dans le cadre d'une thérapie combinatoire avec d'autres anti-viraux, dont ceux décrits ici.
PCT/US2006/046399 2005-12-02 2006-12-04 Composes et methodes permettant d'inhiber une entree virale Ceased WO2007065032A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74199605P 2005-12-02 2005-12-02
US60/741,996 2005-12-02

Publications (2)

Publication Number Publication Date
WO2007065032A2 WO2007065032A2 (fr) 2007-06-07
WO2007065032A3 true WO2007065032A3 (fr) 2007-12-13

Family

ID=38092909

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/046399 Ceased WO2007065032A2 (fr) 2005-12-02 2006-12-04 Composes et methodes permettant d'inhiber une entree virale

Country Status (1)

Country Link
WO (1) WO2007065032A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015130947A1 (fr) * 2014-02-26 2015-09-03 Howard University Utilisation de dérivés benzène-sulfonamides comme inhibiteurs de l'intégrase du vih

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040167096A1 (en) * 2003-02-19 2004-08-26 Yung-Chi Cheng Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections
US6812365B2 (en) * 1999-06-14 2004-11-02 The Arizona Disease Control Research Commission Disulfone reagents and methods of preparing and using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812365B2 (en) * 1999-06-14 2004-11-02 The Arizona Disease Control Research Commission Disulfone reagents and methods of preparing and using same
US20040167096A1 (en) * 2003-02-19 2004-08-26 Yung-Chi Cheng Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections

Also Published As

Publication number Publication date
WO2007065032A2 (fr) 2007-06-07

Similar Documents

Publication Publication Date Title
WO2006113470A3 (fr) Procede pour traiter un cancer grace a l'inhibition combinee d'activites de proteasome et de telomerase
WO2004062613A3 (fr) Inhibiteurs d'integrase hiv
WO2009055335A3 (fr) Inhibiteurs des protéases du vhc
AP2313A (en) Inhibitors of hepatitis C virus RNA-dependent RNA ploymerase, and compositions and treatments using the same.
WO2005030751A3 (fr) Inhibiteurs de dipeptidyle peptidase
WO2006078287A3 (fr) Inhibiteurs de pde4b
WO2006133271A3 (fr) Compositions et methodes portant sur une therapie photodynamique ciblee
WO2010030538A3 (fr) Composés destinés au traitement de l'hépatite c
WO2008127364A3 (fr) Composés antiviraux et utilisation de ceux-ci
WO2006015159A3 (fr) Inhibiteurs de canal a potassium
AU2005235116A1 (en) Combinations for treating HIV infection
NZ577393A (en) Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction
WO2006050480A3 (fr) Pyridines substituees et leurs utilisations
IL181909A0 (en) Phosphoindoles as hiv inhibitors
TW200800969A (en) Compounds
WO2009156182A3 (fr) Dérivés de l'uracile et leur utilisation
WO2010052559A8 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament.
WO2006066950A3 (fr) Aminoalcools tricycliques, procedes de realisation associes et utilisation comme anti-inflammatoires
WO2005121138A3 (fr) Composes heterotricycliques utilises comme inhibiteurs du vhc
WO2007050348A3 (fr) Inhibiteurs du canal potassique
WO2004108770A8 (fr) Agents de migration de chaine peu odorants pour une polymerisation radicalaire commandee
WO2013052006A8 (fr) Inhibiteurs de parp-1
WO2005092924A3 (fr) Rab9a, rab11a et leurs modulateurs lies a une maladie infectieuse
WO2007065032A3 (fr) Composes et methodes permettant d'inhiber une entree virale
WO2006113426A3 (fr) Traitement de cancer par inhibition combinee des activites de la telomerase et de la tubuline

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06844843

Country of ref document: EP

Kind code of ref document: A2